Immunotherapies and drug screening in improved patient-derived models: a translational approach towards personalized treatments for leukaemia

Project Details

AcronymI2TRON Vanessa Klapp
StatusActive
Effective start/end date1/09/22 → 30/08/26

Funding

  • FNR - Fonds National de la Recherche: €179,464.00